A reasonable starting framework, based on extrapolation from GLP-1 nasal delivery literature, might look like this: Conservative approach: Begin with 0.5-1mg per nasal actuation, administered once daily
Benefits of Switching From Semaglutide to Tirzepatide Improved Glycemic Control : A major study indicated that tirzepatide offers better hemoglobin A1c reduction (a marker for blood sugar levels) compared to semaglutide
Our compounded Tirzepatide comes from certified U.S
Studies show that the combined use of Y1 receptor agonists and GLP-1 receptor agonists (GLP-1RA) can induce -cells into a rest state in an obesity-driven diabetes model and promote the recovery of -cell function ( Regulating the proliferation of intestinal L cells and PYY secretion can endogenously increase PYY levels, avoiding the side effects of exogenous administration
Constipation or diarrhea Digestive changes can go either direction
It requires a physicians order, must be administered by a licensed RN (in most states), and must be preceded by appropriate client screening